Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update

Go back to Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update
GALECTIN (NASDAQ: GALT) Delayed: 2.88 +0.05 (1.77%)
Previous Close $2.83    52 Week High $3.05 
Open $2.82    52 Week Low $0.49 
Day High $2.99    P/E N/A 
Day Low $2.80    EPS $-1.32 
Volume 139,062